The Feasibility of Using the PulsePoint to Facilitate Overdose Education and Naloxone Distribution

Part of paid clinical trials in Bloomington, Indiana.

Sponsor
Indiana University
Study ID
NCT06523985
Status
Enrolling By Invitation

Conditions

  • Being Trained to Respond to an Opioid Overdose
  • Carrying Naloxone/Narcan on Their Person or in Their Vehicle

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

  • Push messages (standard) — BEHAVIORAL
    Push messages will be developed based on best practice recruitment principles in cooperation with an external marketing team and then reviewed and finalized by the study team. Messages will be different each month and sent across 12 months. The monthly time frame was selected based on our need to balance contact with responders and research or expert opinions on push messaging saturation.
  • Push messages (customized) — BEHAVIORAL
    These messages are similar to content in the standard push messages but are customized to address common misperceptions about opioid overdose and naloxone.

Study Details

This study is a feasibility trial to assess whether, in a random sample of 180 agencies where PulsePoint is already active, revised procedures (hereinafter PulsePoint-OD) to facilitate opioid overdose and naloxone distribution (OEND) can successfully recruit first responder agencies and layperson responders. For this study, agency refers to a single implementation site where PulsePoint is active and that is bound by the service area or jurisdiction of the first responder agency collaborating with PulsePoint. The study will test the following hypotheses: H1: more first responder agencies will be successfully recruited by arm 2 than by arm 1. H2: more layperson responders will report engaging with OEND programming in arm 2 than in arms 1 or 3 and in arm 1 than in arm 3 \[only this hypothesis is covered by the IRB, hypothesis 1 is not human subjects research\].

Key Dates

Start date
Aug 7, 2024
Status verified
Jun 2025
Primary completion
May 31, 2026
Completion
Sep 30, 2026

Study Design

Enrollment
5,000 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Active Comparator: Standard layperson messaging (Arm 1)
    Users randomized to arm 1 will receive standard monthly recruitment push messages. These push messages will differ from the certification messages because they will contain language intended to foster engagement with OEND services (eg, to get trained and carry naloxone) alongside the link to a landing page.
  • Experimental: Customized layperson messaging (Arm 2)
    Arm 2 will follow the same procedures that are described for arm 1 but will use separate messaging. Specifically, the push messages and landing page will contain additional, brief messages that specifically provide factual information that counteracts misperceptions about overdose and naloxone.
  • No Intervention: Control arm (Arm 3)
    Arm 3 functions as the control arm and will not receive any monthly recruitment messaging or encouragement.

Primary Outcome Measure

Certification of receiving OEND programming and naloxone carrying [ Time Frame: 12 months ]

Locations (1)

FacilityCityStateZIPSite coordinators
Indiana University BloomingtonBloomingtonIndiana47405-

Find similar trials in Bloomington, IN